吉林大学学报(医学版)

• 基础研究 • 上一篇    下一篇

sirtinol对前列腺癌DU145细胞周期的影响及其机制

张大田,石建国,张强,刘岩   

  1. (辽宁医学院附属第一医院泌尿外科,辽宁 锦州 121001)
  • 收稿日期:2014-02-14 出版日期:2014-09-28 发布日期:2014-09-28
  • 通讯作者: 刘 岩 E-mail:(Tel:0416-419763,E-mail:liuyanforest@163.com)
  • 作者简介:张大田(1969-),男,吉林省通化市人,副主任医师,医学硕士,主要从事泌尿系统肿瘤的生物学研究。
  • 基金资助:

    辽宁省科技厅科学计划项目资助课题(2011225015)

Influence of sirtinol in cell cycle of prostate cancer DU145 cells and its mechanism

ZHANG Da-tian,SHI Jian-guo,ZHANG Qiang,LIU Yan   

  1. (Department of Urinary Surgery,First Affiliated Hospital,Liaoning Medical University,Jinzhou 121001,China)
  • Received:2014-02-14 Online:2014-09-28 Published:2014-09-28

摘要:

目的:观察沉默信息调节因子1(SIRT1)抑制剂sirtinol对前列腺癌DU145细胞生长增殖、细胞周期进程和细胞周期正性调节蛋白Cyclin D1、CDK4及pRb 表达的影响,探讨SIRT1在前列腺癌发生中的可能作用机制。方法:取处于对数生长期DU145细胞随机分为对照组(DMSO组)和sirtinol组(终浓度分别为10、25和50  μmol?L-1),MTT法测定各组DU145细胞生长抑制率,RT-PCR和Western blotting法检测DU145细胞中SIRT1 mRNA和蛋白表达水平,流式细胞术检测细胞周期进程,Western blotting法检测DU145细胞中细胞周期蛋白Cyclin D1、CDK4和pRb的表达水平。结果:与对照组比较,各浓度sirtinol组DU145细胞生长抑制率明显升高(P<0.01),G1期细胞明显增多(P<0.01),且呈浓度依赖性。与对照组比较,各浓度sirtinol组DU145细胞中SIRT1 mRNA和蛋白表达水平明显降低(P<0.01),Cyclin D1和pRb蛋白表达水平降低(P<0.01),CDK4蛋白表达无明显变化(P>0.05)。结论:下调SIRT1表达可以抑制前列腺癌DU145细胞的增殖和阻滞细胞周期进程,其机制可能与改变细胞周期蛋白CyclinD1和pRb的表达有关。

关键词: sirtinol, 沉默信息调节因子1, 前列腺肿瘤, DU145细胞

Abstract:

Abstract:Objective
To observe the influence of sirtinol,a silent information regulator 1(SIRT1) inhibitor,in the cell proliferation,cell cycle progression and the expression levels of positive regulator proteins of the cell cycle including Cyclin D1,CDK4  and pRb  in prostate cancer DU145 cells,and to explore the possible mechanism of SIRT1 in  occurrence of prostagte cancer.Methods The DU145 cells at logarithmic growth phase were cultured in vitro and divided into control group(DMSO)and different doses (10,25,50  μmol?L-1) of sirtinol  groups.The inhibitory rate of  growth of DU145 cells was detected with MTT method,the SIRT1 mRNA and protein expression levels were determined by RT-PCR and Western blotting method,and the cell cycle was measured by flow cytometry.The Cyclin D1,CDK4 and pRb protein expression levels were examined by Western blotting method.Results Compared with control group,the inhibitory rates of growth of the DU145 cells in different doses of sirtinol groups were increased markedly in a dose-dependent manner(P<0.01),and the flow cytometry analysis result showed the DU145 cells at G1 phase were increased(P<0.01).Compared with control group,the expression levels of SIRT1 mRNA and protein in DU145 cells in different doses of sirtinol groups were decreased significantly(P<0.01);the expression levels of  Cyclin D1 and pRb proteins were decreased(P<0.01),whereas the expression levels of CDK4 had no change(P>0.05).Conclusion SIRT1 inhibition by sirtinol can inhibit the cell growth of prostate cancer DU145 cells in a dose-dependent manner and arrest the cell cycle progression,and its mechanism may be related to decreasing the CyclinD1 and pRb protein expressions.

Key words: sirtinol, silent information regulator 1, prostate neoplasms, DU145 cells

中图分类号: 

  • R737.25